Conventional transarterial chemoembolization (cTACE)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Conventional transarterial chemoembolization (cTACE), covering 2018-03-29 to 2018-03-29. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Controlled Phase III Trial of Sorafenib With or Without cTACE in Patients With Advanced HCC [Phase 3]